Manuel Mayr
- Cancer Research top 0.1%
- MicroRNA in disease regulation 41
- Cancer-related molecular mechanisms research 28
- Protease and Inhibitor Mechanisms 25
-
- Cardiac Fibrosis and Remodeling 17
- Molecular Biology top 0.2%
- Metabolomics and Mass Spectrometry Studies 30
- Circular RNAs in diseases 24
- Immunology top 0.5%
- Atherosclerosis and Cardiovascular Diseases 26
- Immunology and Allergy top 1%
-
- Advanced Proteomics Techniques and Applications 40
- Co-authors
- Qingbo XuStefan KiechlXiaoke YinJohann WilleitAnna ZampetakiPeter WilleitUrsula MayrYanhua Hu
- Partner nations
- United KingdomAustriaUnited States
In The Last Decade
Manuel Mayr
276 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Cancer Research 5.9k
- Cardiology and Cardiovascular Medicine 4.3k
- Molecular Biology 11.0k
- Immunology 3.0k
- Immunology and Allergy 560
Countries citing papers authored by Manuel Mayr
This map shows the geographic impact of Manuel Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Mayr more than expected).
Fields of papers citing papers by Manuel Mayr
This network shows the impact of papers produced by Manuel Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Mayr. The network helps show where Manuel Mayr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuel Mayr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 25 | |
| 5 | 2023 | 69 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 39 | |
| 12 | 2020 | 153 | |
| 13 | 2017 | 32 | |
| 14 | 2015 | 36 | |
| 15 | 2015 | 95 | |
| 16 | 2014 | 10 | |
| 17 | 2013 | 0 | |
| 18 | 2012 | 168 | |
| 19 | 2010 | 47 | |
| 20 | 2001 | 190 |
About Manuel Mayr
Manuel Mayr is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Spectroscopy, Molecular Biology and Immunology, having authored 288 papers that have together received 20.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (41 papers), Advanced Proteomics Techniques and Applications (40 papers), Metabolomics and Mass Spectrometry Studies (30 papers), Cancer-related molecular mechanisms research (28 papers), Atherosclerosis and Cardiovascular Diseases (26 papers), Protease and Inhibitor Mechanisms (25 papers), Circular RNAs in diseases (24 papers) and Cardiac Fibrosis and Remodeling (17 papers). The work is most often cited by research in Cancer Research (5.9k citations), Cardiology and Cardiovascular Medicine (4.3k citations), Molecular Biology (11.0k citations), Immunology (3.0k citations) and Immunology and Allergy (560 citations). Manuel Mayr has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Qingbo Xu, Stefan Kiechl, Xiaoke Yin, Johann Willeit, Anna Zampetaki, Peter Willeit, Ursula Mayr, Yanhua Hu, Ignat Drozdov and Friedrich Oberhollenzer. Their work appears in journals such as Circulation Research, Cardiovascular Research, Circulation, Arteriosclerosis Thrombosis and Vascular Biology and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.